Cellular immunotherapy using dendritic cells against multiple myeloma

Cellular therapy with dendritic cells (DCs) is emerging as a useful immunotherapeutic tool to treat multiple myeloma (MM). DC-based idiotype vaccination was recently suggested to induce idiotype-specific immune responses in MM patients. However, the clinical results so far have been largely disappoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen-Pham, Thanh-Nhan, Lee, Youn-Kyung, Lee, Hyun-Ju, Kim, Mi-Hyun, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317466/
https://www.ncbi.nlm.nih.gov/pubmed/22479274
http://dx.doi.org/10.5045/kjh.2012.47.1.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317466/
https://www.ncbi.nlm.nih.gov/pubmed/22479274
http://dx.doi.org/10.5045/kjh.2012.47.1.17

Ejemplares similares